Results 111 to 120 of about 10,096 (205)

Low DLG2 gene expression, a link between 11q-deleted and MYCN-amplified neuroblastoma, causes forced cell cycle progression, and predicts poor patient survival [PDF]

, 2020
Simon Keane, Sophie Améen, Angelica Lindlöf, Katarina Ejeskär   +3 more
openalex   +1 more source

Table7_Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma.XLSX

, 2021
Yuren Xia (11176598), Xin Li (51274), Xiangdong Tian (1720804), Qiang Zhao (105948)   +3 more
openalex   +2 more sources

Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells. [PDF]

Cancer Sci, 2023
Mukae K, Takenobu H, Endo Y, Haruta M, Shi T, Satoh S, Ohira M, Funato M, Toguchida J, Osafune K, Nakahata T, Kanda H, Kamijo T.   +12 more
europepmc   +1 more source

MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma. [PDF]

Int J Mol Sci, 2023
Agarwal P, Glowacka A, Mahmoud L, Bazzar W, Larsson LG, Alzrigat M.   +5 more
europepmc   +1 more source

Impact of 11q Loss of Heterozygosity Status on the Response of High-Risk Neuroblastoma With MYCN Amplification to Neoadjuvant Chemotherapy. [PDF]

Front Pediatr, 2022
Lu XY, Qu LJ, Duan XL, Zuo W, Sai K, Rui G, Gong XF, Ding YB, Gao Q.   +8 more
europepmc   +1 more source

Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report. [PDF]

Clin Cancer Res, 2023
Pinto N, Naranjo A, Ding X, Zhang FF, Hibbitts E, Kennedy R, Tibbetts R, Wong-Michalak S, Craig DW, Manojlovic Z, Hogarty MD, Kreissman S, Bagatell R, Irwin MS, Park JR, Asgharzadeh S.   +15 more
europepmc   +1 more source

Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma. [PDF]

Front Mol Biosci, 2021
Xia Y, Li X, Tian X, Zhao Q.
europepmc   +1 more source

MUC15 is an independent prognostic factor that promotes metastases of MYCN non-amplified neuroblastoma [PDF]

, 2023
Huiqin Guo, Weixin Zhang, Qiuyan Zhang, Meng Li, Haiyun Wang, Di Li, Jiabin Liu, Zhenjian Zhuo, Jing He, Lei Miao, Huimin Xia   +10 more
openalex   +1 more source

Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathology

npj Precision Oncology
A deep learning model using attention-based multiple instance learning (aMIL) and self-supervised learning (SSL) was developed to perform pathologic classification of neuroblastic tumors and assess MYCN-amplification status using H&E-stained whole slide ...
Siddhi Ramesh, Emma Dyer, Monica Pomaville, Kristina Doytcheva, James Dolezal, Sara Kochanny, Rachel Terhaar, Casey J. Mehrhoff, Kritika Patel, Jacob Brewer, Benjamin Kusswurm, Arlene Naranjo, Hiroyuki Shimada, Nicole A. Cipriani, Aliya N. Husain, Peter Pytel, Elizabeth A. Sokol, Susan L. Cohn, Rani E. George, Alexander T. Pearson, Mark A. Applebaum   +20 more
doaj   +1 more source

Prediction of MYCN Amplification, 1p and 11q Aberrations in Pediatric Neuroblastoma via Pre-therapy 18F-FDG PET/CT Radiomics. [PDF]

Front Med (Lausanne), 2022
Qian L, Yang S, Zhang S, Qin H, Wang W, Kan Y, Liu L, Li J, Zhang H, Yang J.   +9 more
europepmc   +1 more source